Literature DB >> 30487201

Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors.

Coralynn Sack1,2,3, Ganesh Raghu1,2.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease of unknown origin that is associated with high morbidity and mortality. In this perspective, we briefly review the current understanding of the pathophysiology of IPF and the importance of environmental triggers as a precipitant of disease. We discuss occult intrinsic and extrinsic environmental factors that affect the lung microenvironment and may contribute to the development and progression of disease. The clinical implications of this framework need to be further elucidated, because prompt identification and elimination of occult exposures may represent a novel treatment modality.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 30487201     DOI: 10.1183/13993003.01699-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

Review 1.  DNA methylation in pulmonary fibrosis and lung cancer.

Authors:  Juan Duan; Baiyun Zhong; Zhihua Fan; Hao Zhang; Mengmeng Xu; Xiangyu Zhang; Yan Y Sanders
Journal:  Expert Rev Respir Med       Date:  2022-06-08       Impact factor: 4.300

2.  The effectiveness of immunosuppressive cyclosporin in attenuating the progression of interstitial lung diseases.

Authors:  Mathew Suji Eapen; Archana Vijay Gaikwad; Isobel E Thompson; Wenying Lu; Stephen Myers; Pawan Sharma; Sukhwinder Singh Sohal
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

3.  Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Kazutaka Takehara; Yasuhiko Koga; Yoshimasa Hachisu; Mitsuyoshi Utsugi; Yuri Sawada; Yasuyuki Saito; Seishi Yoshimi; Masakiyo Yatomi; Yuki Shin; Ikuo Wakamatsu; Kazue Umetsu; Shunichi Kouno; Junichi Nakagawa; Noriaki Sunaga; Toshitaka Maeno; Takeshi Hisada
Journal:  Cells       Date:  2022-01-02       Impact factor: 6.600

Review 4.  The Crucial Role of NLRP3 Inflammasome in Viral Infection-Associated Fibrosing Interstitial Lung Diseases.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2021-09-28       Impact factor: 5.923

5.  A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.

Authors:  Neal Dodia; Diana Amariei; Blaine Kenaa; Doug Corwin; Lydia Chelala; E James Britt; Ashutosh Sachdeva; Irina G Luzina; Jeffrey D Hasday; Nirav G Shah; Sergei P Atamas; Teri J Franks; Allen P Burke; Stella E Hines; Jeffrey R Galvin; Nevins W Todd
Journal:  Respir Med       Date:  2021-02-11       Impact factor: 3.415

Review 6.  The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?

Authors:  Timothy N Perkins; Tim D Oury
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.